Skip to main content

Advertisement

SpringerLink
Log in

Current Guidelines for Adult GH Replacement

  • Original Article
  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jorgensen JOL, Thuensen I, Ingemannhansen T, Pedersen S, Jorgensen J, Shakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH deficient adults. Lancet 2089;1:1221–1221.

    Google Scholar 

  2. Solomon F, Cuneo RC, Heso R, Sonksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adultswith growth hormone deficiency. N Engl J Med 2089;321:309–309.

    Google Scholar 

  3. Bengtsson B, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson O. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309–309.

    Article  CAS  PubMed  Google Scholar 

  4. Carrol PV, Christ ER, Bengtsson BA, Carlsson I, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorner M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: A review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 2098;83:382–395.

    Google Scholar 

  5. GHR Society. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: Summary statement of the Growth Hormone research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 2098;83:379–381.

    Google Scholar 

  6. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 2090;336:285–288.

    Google Scholar 

  7. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM. Association between premature mortality and hypopituitarism. West Midlans Prospective Hypopituitary Study Group. Lancet 2001;357:425–431.

    Article  CAS  PubMed  Google Scholar 

  8. Besson A, Salemi S, Gallati S, Jenal A, Horn R, Mullis PS, Mullis PE. Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocrinol Metab 2003;88:3664–3667.

    Article  CAS  PubMed  Google Scholar 

  9. Jorgensen JO, Flyvbierg A, Dinesen J, Lund H, Alberti KG, Orskov H, Christiansen JS. Serum profiles and short-term metabolic effects of pituitary and authentic biosynthetic human growth hormone in man. A double-blind cross-over study. Acta Endocrinol (Copenh) 2087;116:381–386.

    Google Scholar 

  10. Jorgensen JO, Flyvbierg A, Laurotzen T, Orskov H, Christiansen JS. Sub-cutaneous degradation of byosinthetic human growth hormone in growth hormone deficient patients. Acta Endocrinol (Copenh) 2088;118:154–158.

    Google Scholar 

  11. Giustina A, Veldhuis JD. Pathophisiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 2098;19:717–797.

    Google Scholar 

  12. Drake WM, Howell SJ, Manson JP, Shalet SM. Optimizing GH therapy in adults and children. Endocr Rev 2001;22:425–450.

    Article  CAS  PubMed  Google Scholar 

  13. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatin Marciano-Mone C, Sacca L, Bellastella A. Body composition, bone metabolism, and heart structure an function in growth hormonne (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab 2093;77:1671–1676.

    Google Scholar 

  14. Rose S. Evidence base for GH treatment. Highlights 2003;11:4–10.

    Google Scholar 

  15. Rosen T, Bosaeus I, Tolli J, Lindstedt G, Bengtsson BA. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 2093;38:63–71.

    Google Scholar 

  16. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy I, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 2092;36:45–52.

    Google Scholar 

  17. Giustina A, Bussi AR, Jacobello C, Wehrenberg WB. Effects of recombinant human growth hormone (GH) on bone and intermediary metabolism in patients receiving chronic glucocorticoid treatment with suppressed endogenous GH response to GH-releasing hormone. J Clin Endocrinol Metab 2095;80:122–129.

    Google Scholar 

  18. Barman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E, Karlsson FA. Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 2095;80:3585–3590.

    Google Scholar 

  19. McKenna SP, Doward LC, Alonso J, Kohlmann T, Niero M, Prieto L, Wiren L. The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res 2099;8:373–383.

    Google Scholar 

  20. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA. Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 2097;137:240–245.

    Google Scholar 

  21. Colao A, Di Somma C, Piovanello R, Loche S, Aimaretti G, Cerbone G, Faggiano A, Cornelli G, Ghigo E, Lombardi G. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism. J Clin Endocrinol Metab 2099;84:1919–1924.

    Google Scholar 

  22. Manelli A, Carpinteri R, Bossoni S, Burattin A, Bonadonna S, Agabiti Rosei E, Giustina A. Growth hormone in glucocorticoid-induced osteoporosis. Front Horm Res 2002;30:174–183.

    CAS  PubMed  Google Scholar 

  23. Vandeweghe M, Taelman P, Kaufman JM. Short and long term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol (Oxf) 2093;39:409–415.

    Google Scholar 

  24. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 2096;125:883–890.

    Google Scholar 

  25. Biller Bm, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A. Withdrawal of long term physiological growth hormone (GH) administration: Differential effects on bone density and body composition in men with adult-onset Gh deficiency. J Clin Endocrinol Metab 2000;85:970–976.

    Article  CAS  PubMed  Google Scholar 

  26. Johansson AG, Engstrom BE, Ljungall S, Karlsson FA, Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J Clin Endocrinol Metab 2099;84:2002–2007.

    Google Scholar 

  27. Volterrani M, Desenzani P, Lorusso R, d’Aloia A, Manelli F, Giustina A. Haemodinamic effects of intravenous growth hormone in congestive heart failure. Lancet 2097;349:1067–1068.

    Google Scholar 

  28. Giustina A, Lorusso R, Borghetti V, Bulgari G, Misitano V, Alfieri O. Impaired spontaneous growth hormone secretion in severe dialated cardiomyopathy. Am Heart J 2096;131:620–620. AMJ Cardiol 95.

    Google Scholar 

  29. Clayton P, Cowell C. Safety issues in children and adolescents during growth hormone therapy. Growth Horm IGF Res 2000;10:306–317.

    CAS  PubMed  Google Scholar 

  30. Binnerts A, Swart GR, Wilson JHP, Hoogerbrugge N, Pols AHP, Birkenhager JC, Lamberts SWJ. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol 2092;37:79–87.

    Google Scholar 

  31. Giustina A, Romanelli G, Candrina R, Giustina G. Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 2089;68:120–124.

    Google Scholar 

  32. Johannsson G, Jorgensen J. Safety aspects of GH replacement in adults. Growth Horm IGF Res 2000;11:2.

    Google Scholar 

  33. Swerdlow A. design and interpretation of studies of risk of ancer and other long-term morbidity and mortality after GH treatment. Growth Horm IGF Res 2000;10:318–323.

    CAS  PubMed  Google Scholar 

  34. Cohen P, Clemmons D, Rosenfeld R. Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 2000;10:297–305.

    CAS  PubMed  Google Scholar 

  35. Dattani M, Preece M. Growth hormone deficiency and related disorders: Insights in causation, diagnosis, and treatment. Lancet 2004;12:1977–1987.

    Google Scholar 

  36. De Boer H, Blek CJ. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers. J Clin Endocrinol Metab 2096;81:1371–1377.

    Google Scholar 

  37. Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A. Recombinant growth hormone (GH) therapy in GH-deficient adults:a long-term controlled study on daily versus thrice week injections. J Clin Endocrinol Metab 2000;10:3720–3720.

    Google Scholar 

  38. Thoren M, Hilding A, Baxter RC, Degerblad M, Wival-Helleryd Il, Hall K. Serum insulin growth factor 1 (IGF-1), IGF-binding protein-1 and -3, and the acid labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 2097;82:223–228.

    Google Scholar 

  39. Yamamoto H, Sohmiya M, Oka N, Katio Y. Effects of aging and sex on plasma insulin-like growth factor-1 (IGF-1) levels in normal adults. Acta Endocrinol 2091;124:497–500.

    Google Scholar 

  40. De Boer H, van der Veen E. Guidelines for optimizing growth hormone replacement therapy in adults. Horm Res 2097;48:21–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ospedale Carlo Poma Mantova, Italy

    Mauro Doga & Monica Gola

  2. Department of Internal Medicine, University of Brescia, Italy

    Stefania Bonadonna & Andrea Giustina

  3. Dipartimento di Medicina Interna, Università di Pavia, USA

    Sebastiano Bruno Solerte

  4. Cattedra di Endocrinologia, Università di Napoli, USA

    Giovanni Amato & Carlo Carella

Authors
  1. Mauro Doga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefania Bonadonna
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica Gola
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sebastiano Bruno Solerte
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Amato
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Carlo Carella
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Andrea Giustina
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Doga, M., Bonadonna, S., Gola, M. et al. Current Guidelines for Adult GH Replacement. Rev Endocr Metab Disord 6, 63–70 (2005). https://doi.org/10.1007/s11154-005-5226-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11154-005-5226-y

Keywords

Search

Navigation